[1]
Surti, R.P. 2021. Current treatment approaches for breast cancer patients with HER2-positive disease in the adjuvant, and neo-adjuvant setting. International Journal of Basic & Clinical Pharmacology. 10, 5 (Apr. 2021), 596–608. DOI:https://doi.org/10.18203/2319-2003.ijbcp20211661.